Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The investigators performed a randomized, double blind controlled, prospective study method
on observation of Traditional Chinese Medicine (TCM) combined with targeted therapy
maintenance to prolong the efficacy of long-term survival of advanced pulmonary
adenocarcinoma patients. The investigators plan to involve 200 cases for observation in 3
years (100 cases for targeted therapy maintenance, 100 cases for targeted therapy maintenance
plus TCM,), expecting that integrated TCM combined with targeted maintenance therapy has a
better efficacy on prolonging progression-free survival time, overall survival, improving
quality of life(QOL) of patients than that of targeted maintenance therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Collaborators:
Shanghai Chest Hospital Shanghai Pulmonary Hospital, Shanghai, China